trending Market Intelligence /marketintelligence/en/news-insights/trending/cpMgWqxz4vtIHB5Llvmvsg2 content esgSubNav
In This List

Sol-Gel Technologies prices $10M ordinary share offering

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Sol-Gel Technologies prices $10M ordinary share offering

Sol-Gel Technologies Ltd. priced an underwritten public offering of 1,250,000 ordinary shares at $8 per share.

The Israel-based dermatology company also granted underwriters a 30-day option to buy up to an additional 187,500 ordinary shares at the same price.

Gross proceeds are expected to be about $10 million. Sol-Gel plans to use net proceeds for the pre-commercialization activities for its skin creams Epsolay and Twin.

Part of the proceeds will also be used for working capital and other general corporate purposes.

Jefferies LLC is acting as sole book-running manager for the offer.

The offering is expected to close on or about Aug. 12.